|
|
Article: ABILIFY(R) (aripiprazole) Granted Approval for New Indication.
- Article from:
- PR Newswire
- Article date:
- March 7, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Efficacy Was Maintained With ABILIFY in Patients with Bipolar I Disorder With a Recent Manic or Mixed Episode Who Had Been Stabilized and Then Maintained for at Least Six Weeks
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) approved ABILIFY(R) (aripiprazole) Tablets and Oral Solution for maintaining efficacy in patients with Bipolar I Disorder with a recent manic or mixed episode who had been stabilized and then maintained for at least six weeks. The FDA approved ABILIFY for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder, ...